Driving research of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS),
Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia and Post COVID .

OMF Founder and CEO/President Linda Tannenbaum sends this update from the ongoing Invest in ME Research Conference Week in London

OMF Founder and CEO/President Linda Tannenbaum sends this update from the ongoing Invest in ME Research Conference Week in London

The conference is going great! Organizers Richard and Pia Simpson planned a phenomenal 2-day science program once again, with over 100 researchers in attendance. OMF Scientific Advisory Board (SAB) members Ron Davis, Ron Tompkins, Oystein Fluge and Wenzhong Xiao, as well as OMF Science Liaison Chris Armstrong, spoke yesterday. OMF SAB Members Jonas Bergquist and…

Read More

Stay Informed

Be the first to hear our research news.

Subscribe Now.

No thanks